Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling

Cooper, Alasdair CFleming, Ian NPhyu, Su MSmith, Timothy A D2016-08-312016-08-312015-09Cooper, A C, Fleming, I N, Phyu, S M & Smith, T A D 2015, 'Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling', Journal of Cancer Research and Clinical Oncology, vol. 141, no. 9, pp. 1523-1532. https://doi.org/10.1007/s00432-015-1909-20171-5216ORCID: /0000-0001-9505-6418/work/86450275http://hdl.handle.net/2164/7402103778955engSDG 3 - Good Health and Well-beingmetforminbreast cancerHER2[18F]FDGdoxorubicinRC Internal medicineRCChanges in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signallingJournal article10.1007/s00432-015-1909-21419